作者
Marta Gladych, Aneta Wojtyla, Blazej Rubis
发表日期
2011/8
来源
Biochemistry and cell biology
卷号
89
期号
4
页码范围
359-376
出版商
NRC Research Press
简介
Since telomerase has been recognized as a relevant factor distinguishing cancer cells from normal cells, it has become a very promising target for anti-cancer therapy. A correlation between short telomere length and increased mortality was revealed in many studies. The telomerase expression/activity appears to be one of the most crucial factors to study to improve cancer therapy and prevention. However, this multisubunit enzymatic complex can be regulated at various levels. Thus, several strategies have been proposed to control telomerase in cancer cells such as anti-sense technology against TR and TERT, ribozymes against TERT, anti-estrogens, progesterone, vitamin D, retinoic acid, quadruplex stabilizers, telomere and telomerase targeting agents, modulation of interaction with other proteins involved in the regulation of telomerase and telomeres, etc. However, the transcription control of key telomerase …
学术搜索中的文章
M Gladych, A Wojtyla, B Rubis - Biochemistry and cell biology, 2011